-
Published10/01/2025
-
Deadline11/02/2025
-
Today11/02/2025
-
Opening of tenders11/02/2025
Utilities
- indicates text translated automatically in your browsing language
Medicinal products for the cardiovascular system XXII. - Alirocumab Text automatically translated in your browsing language Automatically translated
The subject of the public contract is the supply of medicinal products for parenteral administration containing the active substance alirocumab (ATC group C10AX14) for the treatment of patients in approved indications according to the SPC valid on the date of submission of tenders. Text automatically translated in your browsing language Automatically translated
https://nen.nipez.cz/verejne-zakazky
https://nen.nipez.cz/verejne-zakazky
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.